Advertisement
Advertise on MSK
Musculoskeletal Report
January 04, 2011
MSK Report Video Podcasts

Meeting Highlights

ISEMIR 2009: Video coverage of the Meeting
Miami, March 27, 2009
RWCS 2009: Video coverage of the Symposium
Maui, January 14-17, 2009
ACR 2008: News from the Annual Scientific Meeting
San Francisco, October 24-29, 2008
EULAR 2008: Coverage of the Congress
Paris, June 11-14, 2008
ISEMIR 2008: Video coverage of the Meeting
Chicago, April 10, 2008
AAOS 2008: News from the Annual Meeting
San Francisco, March 5-9, 2008

Affiliations

Arthritis Research
Lupus Research Institute - Letting Science Lead the Way to a Cure
RSS Feeds
advertisement
Ad Women's Healthcare Forum

EULAR 2008 News


Exercise Helps Prevent Knee OA in the Young and the Young at Heart
June 25, 2008
Moderate exercise may help prevent knee osteoarthritis (OA) in young and middle-aged individuals…


Nearly Half of Undifferentiated Arthritis Patients Can Achieve Drug-Free Remission After 1 Year of MTX
June 24, 2008
The chance of achieving drug-free arthritis remission after 1 year of MTX therapy is 46% and is predicted by a negative ACPA status, no or low radiographic damage at baseline, increased age, and shorter disease duration…


Steroids Injections May Prevent Rheumatoid Arthrits From Developing
June 24, 2008
A 3-week course of IM steroids may stop the progression of early rheumatoid arthritis…


Hip Fracture Hospitalizations Drop in US Despite Aging Population
June 23, 2008
New research conducted by a 17-year-old high school student suggests that the US is having a significant impact on the osteoporosis epidemic...


Briobacept May Follow Rituximab as B-Cell Directed Treatment in Rheumatoid Arthritis
June 20, 2008
Briobacept, which targets B-cell activating factor (BAFF), can be given repeatedly to reduce CD19+CD27- B-cells in rheumatoid arthritis patients...


Longitudinal MRI Study Confirms that Rituximab Stops Progression in RA, Suggests Some Regression
June 20, 2008
Imaging studies done 1 year after rituximab (RTX) treatment for rheumatoid arthritis (RA) confirm that progression of joint damage was stopped, and suggest that there may even have been some regression of established damage...


Infliximab (Remicade®) Plus Combination DMARD Therapy for Early RA Increases Remission Rate, Slows Radiological Progression
June 19, 2008
Adding infliximab (INF) to effective combination DMARD therapy for patients with early RA both increases the remission and slows progression of joint damage...

Result Page:  (   [ 1 ]   2    3  )   Next »